AISAP Cardio vs Rapid RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AISAP
VS
by RapidAI (formerly iSchemaView)

AI Verdict

AISAP Cardio and Rapid RV/LV are adjacent healthcare-AI tools, both leveraging AI for cardiac assessment but differing significantly in their approach. AISAP Cardio provides comprehensive cardiac diagnostic assessments from point-of-care ultrasound for structural heart disease and heart failure, whereas Rapid RV/LV focuses on analyzing CTPA scans to determine pulmonary embolism severity through RV/LV ratio measurements. Therefore, selection depends on the specific imaging modality and clinical condition being evaluated.

Choose AISAP Cardio if…

Choose AISAP Cardio if your clinical setting requires a comprehensive, AI-powered point-of-care ultrasound solution for rapid cardiac diagnostic assessments at the bedside. This tool is ideal for early detection and detailed evaluation of structural heart disease and heart failure, including valvular pathologies and various ventricular and atrial measurements, directly within the workflow.

View AISAP Cardio →

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is a rapid, AI-driven assessment of pulmonary embolism severity directly from CTPA scans. This tool specializes in automatically measuring right and left ventricle ratios to quickly identify patients at higher risk, streamlining triage and notification processes within a broader PE management solution.

View Rapid RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AISAP Cardio Rapid RV/LV
Pricing Unknown Contact vendor for pricing information.
Deployment Cloud-based On-premises (dedicated server or virtual machine) or hybrid (on-premises/cloud with secure link to cloud), connecting to hospital LAN/firewall.
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio excels in usability by empowering non-cardiologists and clinicians with basic scanning skills to perform comprehensive cardiac diagnostics at the point of care. It provides real-time feedback during image acquisition, acting as a 'safety net' to ensure high-quality images, which significantly broadens its accessibility and ease of use for a wider range of healthcare providers.

Clinical Value

AISAP Cardio

Both tools are FDA-cleared and offer significant clinical value. However, AISAP Cardio provides a broader and more comprehensive cardiac assessment, enabling early detection of various structural heart diseases and heart failure at the point of care. Clinical studies have validated its ability to allow non-cardiologists to achieve diagnostic accuracy comparable to expert cardiologists, demonstrating 93% sensitivity and specificity for major valve diseases.

Pricing & Value

Rapid RV/LV

While both tools require direct vendor contact for specific pricing, RapidAI offers slightly more transparency by detailing a custom enterprise pricing model based on institution size, patient volume, and required modules, with an annual subscription structure and a stated starting price for a single module. This provides a clearer understanding of its value proposition within an enterprise context, despite the lack of public pricing specifics for individual purchases.

Enterprise Readiness

Rapid RV/LV

Rapid RV/LV demonstrates superior enterprise readiness with explicit statements of HIPAA compliance, BAA availability, and a comprehensive list of certifications including GDPR, ISO 13485, ISO 27001, ISO 27701, and SOC2 Type 1. Its flexible deployment options (on-premises or hybrid) further cater to diverse hospital IT infrastructures and stringent data governance requirements.

Innovation

AISAP Cardio

Both tools are innovative, but AISAP Cardio stands out by being the 'first company in the world to secure FDA clearance in the CADx pathway for the comprehensive diagnosis of structural heart diseases using POCUS.' Its ability to empower non-cardiologists to perform expert-level cardiac diagnostics at the bedside represents a more disruptive innovation in democratizing advanced cardiac care.

Support & Docs

Rapid RV/LV

RapidAI provides a clearly defined and robust support structure, including 24/7/365 customer support via email and phone, along with access to live and recorded training sessions, expert guides, videos, and a dedicated help center. AISAP Cardio mentions education tools and bedside training, but lacks the explicit, comprehensive, and globally available support details offered by RapidAI.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AISAP Cardio Rapid RV/LV
Product Name AISAP Cardio Rapid RV/LV
Company Aisap RapidAI (formerly iSchemaView)
Primary Clinical Focus Rapid, comprehensive cardiac diagnostic assessments and measurements at the bedside, early detection of structural heart disease and heart failure using POCUS. Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
Key AI-powered Measurements/Analysis Valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio.
Integration Capabilities Existing clinical workflows, EHR/EMR, and PACS. Vendor-agnostic. Integration with Rapid PE solution. Triage and notification capabilities (as part of the broader Rapid platform).

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Rapid RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AISAP Cardio analyzes point-of-care ultrasound (POCUS) data to provide comprehensive cardiac diagnostic assessments. In contrast, Rapid RV/LV by RapidAI analyzes CTPA (CT Pulmonary Angiography) scans to assess pulmonary embolism severity.
AISAP Cardio is designed for the early detection of structural heart disease and heart failure, offering rapid and comprehensive cardiac diagnostic assessments at the bedside. Rapid RV/LV focuses specifically on the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans.
AISAP Cardio provides measurements for Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, IVC diameter, and assesses valvular pathologies. Rapid RV/LV automatically measures right and left ventricle diameters and calculates the RV/LV ratio from CTPA images.
AISAP Cardio is designed for use in Cardiology, Emergency Medicine, and Radiology, and can empower non-cardiologists to interpret echocardiograms. Rapid RV/LV is intended for Cardiology, Pulmonology, and Radiology, particularly for assessing pulmonary embolism severity.
AI Tool Finder
AI-powered search. Results may not be comprehensive.